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Summary 
Human neutrophils, monocytes, and eosinophils are known to undergo apoptotic cell death. 
The Fas/Fas ligand pathway has been implicated as an important cellular pathway mediating 
apoptosis in diverse cell types. We conducted studies to examine the importance of the Fas/ 
FasL system in normal human phagocytes. Although Fas expression was  detected on neutro- 
phils,  monocytes, and eosinophils, constitutive expression of FasL was restricted to neutrophils. 
The three types of phagocytes demonstrated differential sensitivity to Fas-induced apoptosis. 
Only neutrophils were highly susceptible to rapid apoptosis in vitro after stimulation with acti- 
vating anti-Fas IgM (mAb CH-11). Fas-mediated neutrophil apoptosis was suppressed by incu- 
bation with G-CSF, GM-CSF, 1FN-',/,  TNF-0~, or dexamethasone, as well as the selective ty- 
rosine kinase inhibitors,  herbimycin A  and genistein.  Spontaneous neutrophil death in vitro 
was partially suppressed by Fas-Ig fusion protein or antagonistic anti-Fas IgGi  (mAb ZB4). In 
coculture experiments, neutrophils released a soluble factor inducing death in Fas-susceptible 
Jurkat cells via a mechanism sensitive to the presence of Fas-Ig or anti-Fas IgG  1. Immunoblot 
analysis using specific anti-human  FasL IgG~ (mAb No. 33) identified a 37-kD protein in ly- 
sates of freshly isolated neutrophils and a 30-kD protein in the culture supematant of neutro- 
phils maintained in vitro. Our results  suggest that mature neutrophils may be irrevocably com- 
mitted to autocrine death by virtue of their constitutive coexpression of cell-surface Fas and 
FasL via a mechanism that is sensitive to proinflammatory cytokines, glucocorticoids, and in- 
hibitors of tyrosine kinase activity. Furthermore, neutrophils can serve as a source of soluble 
FasL, which may function in a paracrine pathway to mediate cell death. 
A 
Poptosis, or programmed cell death, plays a critical role 
in  the  regulation  of inflammation  and  the  host  im- 
mune  response  (1).  Distinct  from necrosis,  the  apoptotic 
process induces  a  series  of coordinated morphologic  and 
biochemical events in the affected cell,  resulting in its de- 
mise and removal by scavenger phagocytes (1). Characteris- 
tically, a cell undergoing apoptosis initially develops cyto- 
plasmic shrinkage and membrane blebbing (zeiosis), which 
is subsequently followed by chromatin condensation (i.e., 
"apoptotic  bodies")  and  DNA  fragmentation.  Although 
these  changes  generally occur sequentially in  an  affected 
cell,  these events may occur separately, subject to the con- 
trol of independent regulatory pathways (2-5). 
The data in this paper were presented  in part in abstract form at the 36th 
Annual Meeting of the American Society  of Hematology,  2-6 December 
1994, Nashville, TN,  and published in  part in  abstract form (Blood. 
84(Suppl. 1):371a). 
The professional human phagocytes -- neutrophils, mono- 
cytes, and eosinophils -- die via apoptosis when maintained 
in vitro (6-15). Mature human neutrophils undergo spon- 
taneous apoptosis most rapidly, resulting in the demise of 
>50% of a population within 48 h  (6, 9-11). Spontaneous 
apoptosis occurs more slowly in eosinophils, where apop- 
totic morphologic features are generally delayed until 48- 
72 h  (14,  15). The rate of spontaneous apoptosis in mono- 
cytes has been reported to vary between that of neutrophils 
and eosinophils, depending partly on the experimental cul- 
ture conditions used (13,  16). 
Although neutrophils appear to be committed to apop- 
totic death in vitro and in vivo, the life span and functional 
activity of mature neutrophils can be extended in vitro by 
incubation with either proinflammatory cytokines, includ- 
ing G-CSF,  GM-CSF,  IFN-y, TNF-o~, and IL-2  (6,  17), 
or glucocorticoids (9,  10). Similarly, spontaneous apoptosis 
is suppressed by TNF-oL, IL-113, GM-CSF, and LPS in mono- 
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phils (14,  15). 
The  Fas  (APO-1;  CD95)/Fas  ligand (FasL)  I  system has 
emerged as an important cellular pathway regulating the in- 
duction  of apoptosis in  a  wide  variety of tissues.  Fas is  a 
widely expressed 45-kD type 1 membrane protein member 
of the TNF/nerve growth factor family of cell surface mol- 
ecules (18-20).  Fas is activated to mediate apoptosis in sus- 
ceptible tissues following interaction with agonistic anti-Fas 
IgM mAb or its natural ligand, FasL, a 37-kD type II pro- 
tein  (18-21).  In  contrast to  the  tissue  distribution of Fas, 
constitutive expression of FasL is relatively limited (19, 20). 
The  biological importance  of the  Fas/FasL system  has 
been extensively studied in T  ceils, where it plays a critical 
role in the clonal deletion of autoreactive T  cells and acti- 
vation-induced suicide ofT  ceils (19, 20, 22-27).  FasL can 
function  in  either autocrine  or paracrine pathways to  cell 
death.  Although  not  constitutively expressed in mature  T 
cells, FasL is induced after activation of mature T  cells by a 
variety of stimuli, including PMA,  ionomycin,  anti-CD3, 
and bacterial superantigen  (22-25).  The  subsequent  inter- 
action of FasL and Fas on  the  cell surface initiates a signal 
transduction  pathway  leading to  autocrine  T  cell suicide 
(22-25). Cytotoxic T  cells can deploy FasL as a death effec- 
tor  molecule in  their strategies to  induce  killing of target 
cells (28, 29). Physiological activation induces FasL expres- 
sion in distinct cytotoxic T  cell clones, which can then use 
FasL to induce apoptosis upon interaction with Fas-bearing 
target cells (28-31).  Furthermore, activated T  cells can se- 
crete  a  biologically active  soluble  form  of FasL  that  may 
possibly contribute to systemic tissue injury during inflam- 
mation (32). 
The role of the Fas/FasL system in the fate of phagocytes 
has been less well characterized. To assess the potential im- 
portance  of this  system  in  the  regulation  of spontaneous 
apoptosis of normal human  phagocytes, we  examined the 
relative surface expression of Fas and  FasL on  neutrophils, 
monocytes,  and  eosinophils. Experiments were  performed 
to determine the relative senstivity of these phagocyte pop- 
ulations  to  Fas-induced apoptosis.  We  also  examined  the 
effects of stimuli known to suppress spontaneous neutrophil 
apoptosis on  Fas-mediated apoptosis in neutrophils. Addi- 
tional experiments were  conducted to  determine whether 
neutrophils  could  serve  as  a  source  of soluble  FasL  and, 
thereby, induce death ofheterologous cells that are suscep- 
tible to the Fas-mediated death pathway. 
Materials  and Methods 
Special Reagents.  The following reagents were obtained from 
commercial sources: FITC-conjugated armexin V (annexin V-FITC) 
(BRAND Applications b.v., Rotterdam, The Netherlands); dex- 
amethasone, progesterone, H-7, acridine orange, 3-[(3-cholami- 
dopropyl)dimethyl-ammonio]-l-propanesulfonate  (CHAPS), Triton 
h  Abbreviations used in this paper: FasL, Fas ligand; MFI, mean fluorescence 
intensity; sFasL,  soluble FasL. 
X-100, human serum albumin (fraction V), and FITC-conjugated 
affiniw-purified F(ab')2 goat anti-human IgG Ab (Sigma Chemi- 
cal Co., St. Louis, MO); genistein (ICN Biomedicals, Cleveland, 
OH); herbimycin A (GIBCO BRL, Gaithersburg, MD); murine 
mAb CH-11  (anti-human Fas [gM); and murine mAb ZB4 (anti- 
human  Fas  IgG/;  Medical &  Biological Laboratories Co.  Ltd., 
Nagoya, Japan, and Upstate Biotechnology Inc., Lake Placid, NY); 
murine  mAb  UB2-FITC  (anti-human  Fas  IgG1;  Oncor,  Inc., 
Gaithersburg, MD);  nmrine  mAb MMA  (anti-CD15  IgM) and 
murine IgG1-FITC control Ab (Becton Dickinson, San Jose, CA); 
and murine mAb No. 33  (anti-human FasL lgG1;  Transduction 
Laboratories, Lexington, KY).  G-CSF and GM-CSF were pur- 
chased from Amgen, Inc.  (Thousand Oaks,  CA) and Immunex, 
Inc.  (Seattle, WA), respectively. IFN-',/ and TNF-(x were pro- 
vided as gifts from Genentech, Inc. (South San Francisco, CA). 
Preparation of Fas-Ig and B7-lg Fusion Proteins.  The Fas-Ig and 
B7-1g fusion proteins were constructed using the procedures es- 
sentially as described by Hollenbaugh and Aruffo (33). The extra- 
cellular domains of human  Fas and human  B7 were isolated by 
PCP, using primers based on previously reported sequences (18, 
34). The resulting fragments were then separately placed in frame 
with the constant region of human  lgGL, Each fusion gene was 
inserted  into  separate  modified  pCDM8  vectors,  which  were 
then transfected into COS cells using DEAE-dextran. At~er 6 d of 
culture, the COS cell supernatants were harvested, and the Fas-lg 
and B7-Ig were purified on protein A affinity colunms. 
Preparation of Pur!fied Populations  qfi Normal Human  Phagocytes. 
Venous blood was collected from normal human volunteers using 
0.2% K,EDTA as an anticoagulant. Neutrophils were isolated by 
sequential sedimentation in Dextran T-500 (Pharmacia LKB Bio- 
technology, Piscataway, NJ) in 0.9% sodium chloride, centrifuga- 
tion in Histopaque-1077  (Sigma Chemical Co.), and hypotonic 
lysis oferythrocytes, as described previously (35). The preparation 
contained >97% PMN, of which >95% were neutrophils. Plate- 
let-depleted monocytes were isolated as described previously (35). 
Eosinophils were isolated by centrifugation on discontinuous gra- 
dients of metrizamide, as described previously (35). The prepara- 
tions contained 95-100% eosinophils, as determined by Wright- 
Giemsa staining of cytocentrifuged samples.  Cell viability- of all 
three populations of phagocytes was >98%, as determined by tD'- 
pan blue exclusion. 
Culture  Conditionsjbr Normal Human Phagocytes.  Preparations 
of isolated normal human phagocytes were maintained in RPMI 
1640-10%  FCS  (supplemented  with  10  mM  Hepes,  0.2  mM 
l~-glutamine,  25 U/ml penicillin, and 25 mg/ml streptomycin) at 
a concentration of 5  X  10  ~' cells/ml in 48-well cell culture clus- 
ters (Costar 3548;  Costar Co., Cambridge, MA) at 37~  in a hu- 
midified CO2  incubator (5%  CO2-95%  air). Aliquots were  re- 
moved and washed once in PBS before use in assays ofneutrophil 
apoptosis (see below). 
lmmunofluorescence Flow  Cytometry  jbr  Detection  qf Fas  Expres- 
sion.  Cell surface expression of Fas was assayed by direct immu- 
nofluorescence flow cytometry using saturating concentrations of 
mAb UB2-FITC. In brief, freshly isolated populations of normal 
human phagocytes (neutrophils, monocytes, and eosinophils) were 
suspended in ice-cold PBS at a concentration of 2 X  10 v cells/ml. 
An  aliquot  of the  respective phagocyte suspension  (50  btl, l()  ~' 
cells) was  added to 50  btl of mAb UB2-FITC dissolved m  PBS 
containing 0.1% BSA and 0.1% sodium azide in the wells of a 96- 
well vinyl microtiter assay plate  (Costar 2596;  Costar)  kept  on 
ice. Cells were stained for 45 min at 4~  washed once with PBS 
containing 0.1% sodium azide, and then fixed with 1% paraform- 
aldehyde in  PBS.  Simultaneous negative  control staining reac- 
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vant murine IgG1-FITC in place ofmAb UB2-FITC. The plates 
were kept at 4~  until the stained cells were analyzed by flow cy- 
tometry using a FACScan  |  and BDIS Consort software (Becton 
Dickinson & Co., Mountain View, CA). Mean fluorescence in- 
tensity (MF]) was calculated by subtraction of the mean fluores- 
cence channel of the appropriate negative control. 
Immunofluorescence Flow Cytometry  for Detection of FasL Expres- 
sion.  Cell-surface expression of FasL on freshly isolated popula- 
tions of normal human phagocytes was assayed by indirect immu- 
nofluorescence flow cytometry using Fas-Ig for primary staining 
and FITC-conjugated, affnity-purified F(ab')2 goat anti-human 
IgG for secondary staining.  In brief, primary staining was per- 
formed with 106 cells incubated with Fas-Ig (20 p,g/nil) in PBS 
containing 10% normal human serum in wells of a 96-well vinyl 
microtiter assay plate  (Costar  2596;  Costar)  kept on  ice.  Cells 
were stained for 45 rain at 4~  then washed once with PBS con- 
taining 0.1% sodium azide and 0.1% BSA. Secondary staining was 
performed with  FITC-conjugated, affinity-purified F(ab')2 goat 
anti-human IgG (10  ~g/ml) in PBS containing 10% goat serum. 
After a single PBS wash, the cells were fixed with 1% paraformal- 
dehyde in PBS. Simultaneous negative control staining reactions 
were performed by omitting Fas-Ig in the primary staining step. 
In separate neutrophil assays, B7-Ig was also substituted for Fas- 
Ig as a negative control. The plates were kept at 4~  until the 
stained cells were analyzed by flow cytometry. 
DNA Electrophoresis.  DNA electrophoresis was performed to 
assess DNA fragmentation.  Normal human  neutrophils, mono- 
cytes, and eosinophils (106 ceils/sample) were removed from cul- 
ture after incubation with mAb CH-11  for 12 h  to induce Fas- 
mediated apoptosis, pelleted by centrifugation, washed once  in 
PBS,  and lysed by the  addition of 0.5  ml lysis buffer  (10  mM 
EDTA, 50 mM Tris,  1% SDS, 250  ~g/ml proteinase K  [Boeh- 
ringer Mannheim,  Mannheim  GmbH,  Mannheim,  Germany], 
pH 8.0) at 37~  for 16 h. DNA was extracted twice with phenol/ 
chloroform/isoamyl alcohol (25:24:1), precipitated with 0.5 vol 
7.5 M  sodium acetate and 2 vol ethanol at -70~  resuspended 
in Tris-EDTA buffer containing 250 p,g/ml RNAse (Boehringer 
Mannheim),  and  incubated  at  65~  for  5  rain  before  electro- 
phoresis in  1.2%  agarose at  50  V  for  3  h.  After staining with 
ethidium bromide, DNA was visualized by UV examination for 
photography. 
Analysis of Apoptotic Cellular  Morphology of Neutrophils.  For  the 
analysis of apoptotic morphology, -'J106  PBS-washed neutro- 
phils were suspended in 1 ml of PBS containing acridine orange 
(5  /~g/ml). An aliquot was then  examined by fluorescence mi- 
croscopy on a Leitz Ortholux microscope (Ernst Leitz, Wetzlar, 
Germany), and cells were scored as apoptotic vs.  nonapoptotic. 
The  morphologic changes of apoptosis in neutrophils are easily 
visualized by this technique,  and they consist of diminution in 
cell volume and chromatin condensation yielding fragmented or 
bright,  homogeneously  stained  nuclei  (1,  10).  500  cells  were 
counted per sample, and data were reported as the percentage of 
ce/ls with apoptotic morphology. 
Quantitation Of  DNA Fragmentation.  Quantitation of DNA frag- 
mentation was performed by determination of fractional solubi- 
lized DNA by diphenylamine assay (10,  36).  In brief, 5  X  106 
PBS-washed neutrophils were lysed in 0.5 ml lysis buffer (5 mM 
Tris-HC1, 20 mM EDTA, 0.5% Triton X-100, pH 8.0), and the 
lysates  were  centrifuged  (15,000 g)  to  separate high  molecular 
weight DNA  (pellet) and cleaved, low molecular weight DNA 
(supematant).  After  precipitation with  0.5  N  perchloric  acid, 
DNA was quantitated by spectrophotometry after the addition 
of diphenylamine reagent. Data are reported as the relative pro- 
portion (percentage) of soluble, low molecular weight DNA. 
Immunofluorescence Flow Cytometry of Annexin  V-FITC  Bind- 
ing.  The  binding of annexin V-FITC was  used as a  sensitive 
measure of neutrophil apoptosis and performed by modification 
of a previously described method  (11).  Specific binding of an- 
nexin V-FITC was performed by incubation ofneutrophils (5 ￿ 
105  cells)  in 50  p,1 of binding buffer (10  mM  Hepes,  140  mM 
NaC1, 2.5 mM CaCI2, pH 7.4) containing a saturating concentra- 
tion of annexin V-FITC for 30 rain at 4~  Nonspecific binding 
was  determined  using  calcium-flee  binding  buffer  (10  mM 
Hepes,  140  mM NaC1,  10 mM EDTA, pH 7.4). After incuba- 
tion, neutrophils were pelleted at 400 g for 10 min at 4~  then 
fixed in  1% paraformaldehyde in PBS and stored in the dark at 
4~  before analysis.  Neutrophils were analyzed within 24  h  of 
fixation in a  Coulter Epics Elite ESP  flow cytometer (Coulter 
Corp.,  Hialeah, FL) while gating on physical parameters to ex- 
clude cell debris. 
Coculture Experiments with Neutrophils and  Jurkat Cells.  Freshly 
isolated neutrophils (2.5 ￿  106/ml) andJurkat cells (2.5 ￿  106/ml) 
were cocultured in R.PMI 1640-10% FCS at 37~  in a humidi- 
fied CO  2 incubator (5% CO2-95% air) in six-weU Transwell tis- 
sue culture plates (Coming Costar Corp., Cambridge, MA). The 
two cell populations were physically separated by a polycarbonate 
membrane with a 0.4-1*m pore size. Specific wells were supple- 
mented with mAb CH-11  (anti-human  Fas  IgM,  100  ng/ml), 
mAb ZB4 (anti-human Fas IgG~, 1 Ixg/ml), or Fas-Ig (50 Izg/ml), 
as indicated in the figure legend. At designated times, aliquots of  the 
Jurkat cells were removed, and viability was determined using a 
commercial fluorescence microscopy viability kit (LIVE/DEAD  | 
Viability/Cytotoxicity  Kit; Molecular Probes, Inc., Eugene, OIL). 
Identification of Membrane-assodated and Soluble FasL  from Neutro- 
phils by Immunoblot.  Lysate  samples of freshly isolated neutro- 
phils (107) from two normal volunteers were prepared in 200 p~l 
of CHAPS lysis buffer, as previously described (35).  Neutrophil- 
conditioned culture supematants were  obtained by maintaining 
neutrophils in vitro in R.PMI  1640  (supplemented with 10 mM 
Hepes, 0.2 mM L-glutamine, 25 U/ml penicillin, and 25 b~g/ml 
streptomycin) plus 0.1% human serum albumin at a concentration 
of 20  ￿  106 cells/ml in 48-well cell culture clusters.  Culture su- 
pematants  were  removed  at  designated time  points,  and  were 
cleared of intact cells and cellular debris by centrifugation. Mem- 
brane-associated FasL from lysates of freshly isolated neutrophils 
and soluble FasL from supematants of neutrophils maintained in 
vitro  were  detected by  immunoblot  analysis  on  Immobilon-P 
polyvinyldiene difluoride membranes (Millipore Corp., Bedford, 
MA) with murine mAb No. 33 (anti-human FasL IgG1). Lysates 
were mixed 1:1 with 2￿  SDS sample buffer and boiled for 5 rain 
immediately before  electrophoretic analysis  (40  I*l  loaded  per 
well)  on  8.5%  SDS  polyacrylamide gels.  Culture  supematants 
were handled similarly, except that aliquots were mixed 2:1 with 
3 X SDS sample buffer before loading. Immunoblots were devel- 
oped using an enhanced chemiluminescence detection kit (ECL; 
Amersham Life Science, Buckinghamshire, UK). 
Statistical Analysis.  Mean  values  were  compared  using  Stu- 
dent's two-tailed t test for independent means; differences were 
not regarded as significant if P >10.05. 
Results 
Differential Cell-surface Expression of Fas and FasL on Normal 
Human Neutrophils, Monocytes, and Eosinophils.  Cell-surface 
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Figure 1.  Cell-surface expression of Fas on normal human phagocytes. Direct immunofluorescence flow cytometry was performed to detect cell sur- 
face Fas expression  on fresl~y  isolated  normal human neutrophils, monocytes, and eosinophils. Data are expressed in the form of a fluorescence histogram 
overlay depicting specific Fas staining (solid line) vs. negative control staining (broken line). Data are representative of five independent experiments with 
similar results. MFI values cited in the text represent mean values _+SD from five independent donors. 
expression of Fas was  detected on  normal human  neutro- 
phils,  monocytes,  and  eosinophils by direct immunofluo- 
rescence  flow cytometry using mAb UB2-FITC  (Fig.  1). 
Fas expression was highest on neutrophils, where the aver- 
age MFI was  19.5  -+ 0.3  (mean  +  SD; log scale; n  =  5 in- 
dependent donors). The relative intensity of Fas expression 
on monocytes and eosinophils was  <50%  of that observed 
on  neutrophils,  with MFI values of 6.2  +  1.6  and  9.0  + 
0.5 for monocytes and eosinophils, respectively (n  =  5 in- 
dependent donors). 
Cell-surface expression of FasL was detected by indirect 
immunofluorescence  flow  cytometry  using  Fas-Ig fusion 
protein.  In contrast  to  Fas,  the  FasL immunofluorescence 
histograms  for  monocytes  and  eosinophils  were  virtually 
superimposable on their respective negative control immu- 
nofluroescence histograms (Fig. 2), yielding MFI values for 
monocytes  and  eosinophils  that  were  not  significantly 
greater than 0  (2.0  •  1.0 and 0.9  _+ 0.4,  respectively In = 
5  independent donors]). Significant FasL expression, how- 
ever,  was detected on neutrophils with an MFI of 12.5  - 
0.9  (n  =  5  independent donors). Substitution of B7-1g for 
Fas-Ig in the initial binding reaction yielded an immuno- 
fluorescence  histogram  superimposable  on  the  negative 
control (data not shown). 
Differential  Sensitivity  of Neutrophils,  Monocytes,  and Eosino- 
phils to Fas-induced Apoptosis.  To determine the relative sen- 
sitivity of normal human neutrophils, monocytes, and eosi- 
nophils to Fas-induced apoptosis, isolated populations of these 
cells were maintained in vitro in serum-containing medium 
and stimulated with agonistic anti-Fas IgM  (rnAb CH-11) 
for  12 h.  Because DNA  fragmentation is considered to be 
the biochemical hallmark ofapoptosis (1), a quantitative as- 
say of DNA fragmentation was peffornaed (Fig. 3 A). Stim- 
ulation by mAb CH-11  induced a dramatic increase in the 
content of low molecular weight DNA in neutrophils from 
a  control value  of 7%  to  48%  (P <0.01).  In  contrast,  the 
proportion of soluble DNA  in monocytes arid eosinophils 
was relatively unaffected by mAb CH-11.  The percentage 
of soluble DNA was unchanged in eosinophils (3% for both 
treated  and  control  cells)  and  only  modestly increased in 
monocytes from a control value of 1-6% (P <0.05). 
The relative sensitivity ofneutrophi/s to Fas-induced DNA 
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Figure 2.  Cell-surface expression of FasL on nomaal human phagocytes. Indirect immunofluorescence flow cytometry was performed to detect cell- 
surface FasL  expression on freshly isolated normal human neutrophils, monocytes, and eosinophils. Data are expressed in the form of a fluorescence histo- 
gram overlay depicting specific FasL  staining (solid line) vs. negative control staining (dotted line). Data are representative of five independent experiments 
with similar results. MFI values cited in the text represent mean values +SD from five independent donors. 
432  Fas and Fas Ligand on Human Phagocytes fragmentation was  confirmed by conventional "DNA  lad- 
der"  analysis  (Fig.  3  B).  Whereas  negligible  or  modest 
DNA  cleavage was present in freshly isolated  (0 h,  lane  1) 
neutrophils  and  neutrophils  maintained in vitro  for  12  h 
(lane 2),  a  substantial level of DNA  cleavage products was 
readily apparent in neutrophils after stimulation with mAb 
CH-11  for 12 h  (lane 3). 
When  undergoing apoptosis,  cells develop  characteristic 
morphologic changes, such as chromatin condensation and 
cytoplasmic  shrinkage,  before  apparent  DNA  fragmenta- 
tion (1,  2,  5).  Stimulation with mAb CH-11  rapidly accel- 
erated  the  development of apoptotic  morphology in neu- 
trophils maintained in vitro (Fig. 3  C). Greater than 30% of 
the  mAb  CH-11-stimulated  population  developed  apop- 
Figure 3.  Differential sensitivity of normal human phagocytes to Fas-induced apoptosis. (A) Fas-induced DNA fragmentation in normal human neu- 
trophils, monocytes, and eosinophils. Freshly isolated populations of normal human phagocytes were maintained in vitro in the absence (control, open 
bars) and presence of mAb CH-11 (100 ng/ml) (diagonally  striped  bars), as indicated. After incubation for 12 h, aliquots of phagocytes were processed for 
quantitation  of DNA fragmentation by the diphenylamine assay method.  Data are reported  as the ratio of DNA cleavage products to high molecular 
weight DNA expressed as a percentage. Results represent the mean -+SE of five separate experiments performed with phagocyte populations isolated 
from independent donors. (B) Gel electrophoresis demonstrating Fas-induced DNA fragmentation in neutrophils maintained in vitro: (lane 1) 0 h (freshly 
isolated); (lane 2) control  X 12 h; (lane 3) mAb CH-11 (100 ng/ml) X 12 h. Lane S represents DNA 1-kb size marker standards (GIBCO BRL). (C) Time 
course of Fas-induced apoptosis in neutrophils maintained in vitro. At the designated time points, aliquots of neutrophils were prepared and scored for 
apoptotic morphology by fluorescence microscopy after staining with acridine orange: (a) control ('"O"'),and  (b) mAb CH-11 (100 ng/ml) (--B-)- Data 
are reported as the percentage of cells demonstrating morphologic features of apoptosis, and they represent the mean +  SD of five separate experiments 
performed with neutrophils isolated from independent donors. Substitution of mAb MMA (anti-CD  15 IgM; 1 p,g/ml) for mAb CH-11 during incuba- 
tion resulted in a rate of apoptosis identical to control (data not shown). (D) Morphologic features of Fas-induced apoptosis in neutrophils. Cytospin prepa- 
rations ofneutrophils maintained in vitro were stained by the Wright-Giemsa method: (1) control ￿  0 h;  (2) control X 12 h; and (3) mAb CH-11  (100 ng/ 
ml) X 12h. 
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Figure 4.  Proinflamnlatory cytokines reduce Fas-induced DNA flag- 
mentation in normal human neutrophils. Neutrophils were maintained 
in vitro in the absence and presence of anti-Pas lgM (mAb CH-11,  100 
ng/ml), as indicated, l)esignated samples of neutrophils were preincu- 
bated with G-CSF (1 p,g/ml), GM-CSF (1 Ixg/ml), IFN-y (100 U/ml), 
or TNF-c~ (100 U/ml) for 1 h before the addition of n~b CH-11. After 
incubation for 12 h, aliquots of neutrophils were processed for quantita- 
tion of  DNA fragmentation by the diphenylamine assay  method. Data are 
reported as the ratio of DNA cleavage  products to high molecular weight 
DNA expressed as percentage. Results represent the mean -+ SE of four 
separate experiments peffomaed with neutrophils isolated from indepen- 
dent donors. Among the neutrophils stinmlated with anti-Fas IgM (mAb 
CH-11), the asterisk denotes a statistically significant difference in DNA 
fragmaentation in  cytokine-treated cdls  as  compared to  control cells 
(p <o05) 
totic morphology within 3 h, compared to <5% ofneutro- 
phils maintained  without mAb CH-11.  By 6  h,  apoptotic 
morphology was apparent in 90% of the neutrophils stimu- 
lated  with  mAb  CH-11.  Neutrophils  maintained  in  vitro 
for 12 h  without mAb CH-11  (Fig. 3 D, panel 2) retained 
morphologic features  essentally  similar  to  those  of freshly 
isolated neutrophils  (panel  t). In contrast, typical apoptotic 
morphologic  features,  consisting  of chromatin  condensa- 
tion ("apoptotic bodies") and reduced cytoplasmic volume, 
were  readily  apparent  in  neutrophils  maintained  in  vitro 
with mAb CH-11 for 12 h  (Fig. 3 D, panel 3). 
Effect of Proinflammatory Cytokines on Fas-induced Apoptosis 
of Neutrophils.  Proinflanmlatory cytokines have been shown 
to  suppress  or delay spontaneous  apoptosis  of neutrophils 
maintained  in vitro  (6).  To determine  whether proinflam- 
matory cytokines could exert a similar suppressive effect on 
Fas-mediated  apoptosis  of neutrophils,  quantitiative  DNA 
fragmentation  assays  were  perfonned  on  neutrophils  pre- 
treated in vitro for 1 h  with  G-CSF  (1  ~g/ml),  GM-CSF 
(1 I.tg/ml), IFNy (100 U/ml), or TNF-ot (100 U/nil) before 
the  addition  of mAb  CH-11  (Fig.  4).  All  four  cytokines 
significantly  reduced  the  development  of low  molecular 
weight DNA induced by activation ofFas (P <0.05). G-CSF 
exerted  the  strongest  effect  on  Fas-mediated  apoptosis, 
reducing  the  percentage  of soluble  DNA  from  a  control 
value of 58% to 29%. Less pronounced, but significant, sup- 
pression  of  Fas-mediated  apoptosis  was  observed  when 
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Figure 6.  Dexamethasone reduces Fas-induced DNA fragmentation in 
normal human neutrophils.  Neutrophils  were maintained in vitro in the 
absence and presence ofanti-Fas lgM (mAb CH-11, 100 ng/ml), as indi- 
cated. Designated samples of neutrophils were preincubated with dexam- 
ethasone (1  ~M) or progesterone (1  I.LM) for 1 h before the addition of 
mAb CH-11. After incubation for  12 h, aliquots of the neutrophil sus- 
pensions were  processed for quantitation  of DNA fragmentation by the 
diphenylamine  assay method.  Data  are  reported  as  the  ratio  of DNA 
cleavage products to  high molecular weight DNA expressed as percent- 
age. P,,esults represent the mean -+ SE of four separate experiments per- 
formed with neutrophils isolated from independent donors. Among the 
neutrophils stimulated with anti-Fas IgM (mAb CH-I I), the asterisk de- 
notes a statistically  significant difference in DNA fragmentation in steroid- 
treated cells as compared to control cells (P <0.05). 
neutrophils were  preincubated with  GM-CSF,  IFN-y,  or 
TNF-cx. 
The ability of G-CSF to suppress Fas-mediated apoptosis 
in neutrophils was confirmed by annexin V-FITC  flow cy- 
tometric  experiments  (Fig.  5).  Apoptosis is associated with 
alterations in plasma membrane structure before the devel- 
opment  of  DNA  fragnlentation  (5).  These  structural 
changes lead to  the exposure of phosphatidylserine on the 
cell surface  early  in  the  apoptotic  process  (11,  37).  Thus, 
apoptotic cells can be detected and quantified by their abil- 
ity  to  bind  annexin V,  a  Ca2+-dependent  phospholipid- 
binding protein  with  high  affinity for  phosphatidylserine 
(11,  38).  High specific binding of annexin V  was detected 
in <2% of freshly isolated neutrophils, compared to  14% of 
neutrophils maintained in vitro for  12 h. Activation of Fas 
by mAb CH-11  increased the percentage ofannexin V-posi- 
tive cells to 78% at  12 h.  Incubation with G-CSF reduced 
the proportion of annexin V-positive cells in Fas-activated 
neutrophil populations to  28%  (mean;  n  =  5  independent 
donors). 
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Figure 7.  Genistein and herbimycin A reduce Fas-induced DNA frag- 
mentation in normal human neutrophils.  Neutrophils were maintained 
in vitro in the absence and presence of anti-Fas IgM (mAb CH-11, 100 
ng/ml), as indicated.  Designated  samples of neutrophils  were  preincu- 
bated with herbimycin A (3 b~M), genistein (50 bLM), or H-7 (50 ~M) for 
1 h before the addition of mAb CH-11. After incubation for 12 h, ali- 
quots of the neutrophil suspensions were  processed for  quantitation  of 
DNA fragmentation  by the diphenylanfine assay method.  Data are re- 
ported as the ratio of DNA cleavage products to high molecular weight 
DNA expressed as percentage, l~esults represent the mean +  SE of four 
separate experiments performed with neutrophils isolated from indepen- 
dent donors. Among the neutrophils stimulated with anti-Fas IgM (mAb 
CH-11), the asterisk denotes a statistically significant difference in DNA 
fragmentation  in cells incubated  with  protein  kinase inhibitor as com- 
pared to control cells (P <0.05). 
Effect of Dexamethasone  on Fas-induced Apoptosis of Neutro- 
phils.  In contrast to their induction ofapoptosis in imma- 
ture T  cells, glucocorticoids suppress the rate  of spontane- 
ous apoptosis in neutrophils maintained in vitro (9,  10). To 
determine  whether  glucocorticoids  could  similarly inhibit 
Fas-mediated neutrophil apoptosis, we compared the relative 
effects of dexamethasone (1  I~M) and progesterone  (1  p~M) 
on  the  development  of DNA  fragmentation  induced  by 
mAb CH-11  (100 ng/ml ￿  12 h) (Fig. 6). Dexamethasone, 
but not progesterone, significantly reduced the percentage of 
soluble, low molecular weight DNA  in mAb CH-11-stim- 
ulated neutrophil populations from 58% to 42% (P <0.05). 
To  confirm  this  finding,  flow  cytometric  analysis  of an- 
nexin V  binding was performed (Fig. 5). The percentage of 
specific annexin V-positive  cells induced by mAb  CH-11 
was reduced from 78%  to  30%  (mean; n  =  5  independent 
donors). 
Effects of Genistein and Herbimycin A  on Fas-induced Apop- 
tosis qfNeutrophils.  Tyrosine kinase activity has  been im- 
plicated as an essential component of the Fas-mediated signal 
Figure 5.  Proinflammatory cytokines, dexamethasone, and genistein reduce Fas-induced apoptosis in normal human neutrophils as detected by an- 
nexin V binding. Immunofluorescence flow cytontetry was performed to detect binding ofannexin V-FITC to neutrophils maintained in vitro. Experi- 
mental conditions: (1) control  ￿  0 h; (2) control  ￿  12 h; (3) n~b CH-11 (100 ng/ml) ￿  12 h; (4) G-CSF (1 Ixg/ml) X 1 h followed by mAb CH-1 l 
(100 ng/n~) X 12 h; (5) dexamethasone (1  p,M) ￿  1 h followed by mAb CH-11  (100 ng/ml) X 12 h; and (6) genestein (50 p,M) ￿  1 h followed by 
mAb CH-11  (100 ng/ml) X 12 h. Data are expressed in the form of a fluorescence histogram overlay depicting specific annexin V-FITC (broken line) vs. 
nonspecific background binding (solid line). Data are representative of five independent experiments with similar results. Percentages represent the propor- 
tion of neutrophils demonstrating high specific binding of annexin V-FITC (i.e., apoptotic cells). The percentage values cited in the text represent mean 
values from five independent donors. 
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Figure 8.  Spontaneous  neutrophil death in vitro is suppressed by antag- 
onistic anti-Fas lgG~ and Fas Ig. Normal neutrophils were maintained in 
vitro under the following conditions: control (~);  +  anti-Fas IgM 
(mAb CH-11; 100 ng/ml) (...{~}...); + anti-Fas lgG (rnAb ZB4; 1 btg/ml) 
(--i--); + Fas-Ig (50 btg/ml) (---A---);  and + B7-1g (50 ~g/ml) (....C>-). At 
the designated time points, aliquots of the neutrophils were removed, and 
cell viability was detemfined. The data represent the mean -+ SE for four 
independent experiments performed with neutrophils isolated from inde- 
pendent donors. 
transduction  pathway leading to apoptosis  in  T  cells  (39). 
To determine  whether tyrosine kinase  activity is involved 
in Fas-mediated apoptosis in neutrophils, we examined the 
effects of two selective  tyrosine kinase  inhibitors  with  dif- 
ferent mechanisms of action,  genistein  (40),  and herbimy- 
cin A  (41)  on Fas-induced DNA fragmentation in neutro- 
phils  (Fig.  7).  Both herbimycin A  (3  I.tM)  and genistein 
(50  IxM)  significantly  reduced  the  percentage  of soluble, 
low molecular  weight DNA  in populations  of Fas-stimu- 
lated  neutrophils  from 58%  to 28%  and  43%,  respectively 
(P <0.05). In contrast, the protein kinase C  inhibitor, H-7, 
failed to suppress Fas-induced DNA fragmentation. Confir- 
matory  flow  cytometric  experiments  demonstrated  that 
genistein  reduced  the  percentage  of annexin  V-positive 
cells in Fas-stimulated populations ofneutrophils from 78% 
to 40% (mean; n =  5 independent donors) (Fig. 5). 
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Figure 9.  Neutrophils release a soluble factor that induces Jurkat cell 
death. Jurkat cells were cocultured with normal neutrophils in tissue cul- 
ture wells providing physical separation of the two cell populations by a 
porous polycarbonate membrane. Conditions: control, Jurkat cells alone 
(-m--); Jurkat cells +  anti-Fas IgM (mAb CH-11;  100 ng/ml) (~); 
Jurkat cells + nomml  neutrophils (.-.&.-);Jurkat cells + nomlal  neutrophils + 
anti-Fas IgG1 (mAb ZB4; 1 Ftg/ml) ('-'0); and Jurkat cells + nomlal 
neutrophils +  Fas-lg (50 ~g/ml)  (O"')- At the designated time points, 
aliquots of the Jurkat cells were removed, and cell viability was deter- 
nfined. The data represent the mean -+ SE for four independent experi- 
ments performed with neutrophils isolated from independent donors. 
Spontaneous Neutrophil Apoptotic Death Is Partially Inhibited 
by Fas-Ig or Inhibitory anti-Fas IgG.  To  test  whether  the 
Fas system plays a critical role in the control of spontaneous 
neutrophil apoptotic death, neutrophils were maintained in 
vitro with  antagoifistic anti-Fas  IgG1  (mAb No.  33,  1 p,g/ 
nil)  or Fas-Ig (50 Ixg/ml) deployed as a soluble receptor to 
block the interaction of FasL with cell-associated Fas (Fig.  8). 
Both anti-Fas  IgG1 and Fas-Ig significantly reduced spon- 
taneous  neutrophil  death  at  24-72  h  (P <0.05).  At 48  h, 
viability  in  control  neutrophils  declined  to  25%,  but  re- 
mained  >50%  in  neutrophils  treated  with  either  anti-Fas 
IgG1  or  Fas-Ig.  B7-Ig,  used  as  a  negative  control  fusion 
protein, did not significantly affect neutrophil viability. 
Neutrophils  Release  a  Soluble Factor That  Induces Jurkat 
Death.  It has  been  recently  recognized that  FasL can  be 
secreted as a soluble, functionally active ligand (23, 25, 32, 
42,  43).  Thus,  cells  capable of expressing FasL can induce 
death  of heterologous  Fas-susceptible  cells  via a  paracrine 
pathway that does not require  direct cell-cell contact (23- 
25,  32).  Furthermore,  Fas-Ig  fusion  protein  can  be  de- 
ployed as  a  competitive  inhibitor  of Fas/FasL  interactions 
to block the physiological effects of soluble FasL in culture 
supernatants  (23-25). 
Stimulated  neutrophils  are  known  to  secrete  a  soluble 
factor  (or  factors)  that  suppresses  the  biologic  activity  of 
certain  populations  of lymphocytes (44).  This  neutrophil- 
derived  suppressive  activity has been attributed,  at least  in 
part,  to released  myeloperoxidase and  H202  (44).  Because 
FasL is constitutively expressed  on normal neutrophils,  we 
hypothesized another mechanism for the  immunosuppres- 
sive  activity  of neutrophils.  To  test  whether  neutrophils 
could serve  as  a  source  of biologically active soluble  FasL 
(sFasL),  we performed experiments in which Jurkat cells,  a 
cloned human T  cell line is highly susceptible to Fas-medi- 
ated  death  (Fig.  9,  -[21-),  were  cocultured  with  normal 
neutrophils in a system that allows diffusion of soluble fac- 
tors,  but  prevents  physical  contact  between  the  two  cell 
populations.  Neutrophil  coculture reduced Jurkat  viability 
at 72 h to 51%, compared to 91% viability observed in con- 
trol  Jurkat  cells  maintained  in  normal  medium  (Fig.  9). 
Jurkat death induced by coculture with neutrophils was sig- 
nificantly reduced  at  24-72  h  by either  antagonistic  anti- 
Fas-IgG1  (mAb  No.33,  l  I~g/nfl)  or  Fas-Ig  (50  btg/tnl) 
(P <0.05).  Specifically,  Jurkat  viability  at  72  h  was  in- 
creased to 77% and 82% by anti-Fas-IgGi  and  Fas-Ig, re- 
spectively.  These  results  are  consistent  with  the  release  of 
biologically  active  sFasL  by  nornqal  human  neutrophils 
maintained  in vitro,  suggesting a possible  role  for FasL in 
neutrophil-mediated  cytotoxicity. 
hnmunoblot Detection qf lntact, Membrane-associated FasL and 
sFasLfrom Normal Neutrophils.  Whole-cell  lysates  of freshly 
isolated  neutrophils  from  two  normal  donors  were  pre- 
pared,  and  immunoblot  analysis  was  performed  using  an 
mAb specific for human FasL.  A  prominent 37-kD protein 
(Fig.  10, upper arrow) was identified by this technique in the 
neutrophil  lysates  from both  individuals  (Fig.  10,  lanes  1 
and  2).  Samples  of supernatant  were  also  obtained  from 
cultures of these neutrophils  after maintenance  in vitro for 
436  Fas and Fas Ligand on Human Phagocytes Figure 10.  Detection of intact FasL and soluble FasL from normal neu- 
trophils by immunoblot. Immunblot analysis for FasL was performed us- 
ing human  FasL-specific mAb No.  33.  Lysates and culture supernatants 
from two normal donors are shown. Lanes I and 2 represent whole-cell 
lysates of freshly isolated neutrophils from the two donors, respectively. 
Lanes 3-5 and  6-8 represent culture supematants of neutrophils main- 
tained in vitro from the two  donors, respectively. Culture  supernatants 
were obtained at 12 h (lanes 3 and 6), 24 h (lanes 4 and 7), and 48 h (lanes 
5 and 8). Migration positions ofprestained molecular mass markers are in- 
dicated in the left margin. Arrows in the right margin indicate the migra- 
tion positions of proteins recognized by the anti-human  FasL mAb used 
in the immunoblot. 
12-48  h.  A  30-kD  protein  (Fig.  10,  middle arrow) was  de- 
tected by FasL immunoblot  in the  neutrophil  supernatants 
from both  individuals  (Fig.  10:  donor  1,  lanes  3-5,  donor 
2, lanes  6-8).  In the supernatant  from donor  1,  the 30-kD 
protein  signal was faintly apparent at  12  h  (lane  3)  and  in- 
creased in intensity at 24  (lane  4)  and 48  h  (lane  5).  In the 
supernatant  from  donor  2,  the  30-kD  protein  signal  was 
absent at 12 h  (lane 6), but readily apparent by 48 h  (lane  8). 
By 48  h,  a  14-kD  protein  (lower arrow), presumably repre- 
senting  an sFasL degradation  product,  was  detected  in  the 
neutrophil culture supernatants from both individuals  (lanes 
5 and  8). 
Discussion 
The  Fas/FasL  system is  acknowledged  to  play  a  critical 
role  in  the  regulation  of both  T  cell  and  B  cell  develop- 
ment  (19,  20,  22-27,  45).  Whereas  quiescent  T  cells lack 
FasL  expression,  physiologic  activation  of T  cells  in  re- 
sponse to a number of stimuli induces  FasL expression  and 
upregulation  of Fas, whose ensuing engagement on the cell 
surface initiates an autocrine cell death pathway (22-25).  In 
this  manner,  T  cells  appear  not  to  be  committed  but, 
rather,  must  be  induced  by  activation  signals  to  undergo 
apoptosis. 
Our findings invoke a different scenario for the Fas/FasL 
pathway in  neutrophils.  Our  results  not  only confirm  that 
Fas is constitutively expressed on human neutrophils,  mono- 
cytes,  and  eosinophils  (16,  46),  but  they  also  demonstrate 
that,  among normal mature  phagocytes,  FasL expression  is 
restricted  to  neutrophils  (Figs.  1  and  2).  This  constitutive 
coexpression  of Fas  and  FasL  suggests  a  plausible  mecha- 
nism responsible for the rapid rate of spontaneous apoptosis 
observed  in  mature  human  neutrophils.  Unlike  mature  T 
cells,  which  must  be  activated  to  undergo  Fas-rnediated 
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apoptosis,  neutrophils  may  be  irrevocably  committed  to 
autocrine death resulting from Fas/FasL engagement on the 
cell  surface.  Alternatively,  neutrophil  apotosis could  occur 
via a  "fratricide"  pathway in which  membrane-bound  Fas 
interacts with FasL expressed on an adjacent cell (47, 48). 
To  test  the  potential  importance  of the  Fas/FasL  path- 
way  in  regulation  of  spontaneous  neutrophil  apoptotic 
death,  we performed experiments  examining the  effects of 
antagonistic anti-Fas IgG1 and Fas-Ig (deployed as a soluble 
receptor  for  FasL)  on  the  viability  of neutrophils  main- 
tained  in  vitro  (Fig.  8).  Both  agents  significantly  reduced 
spontaneous  neutrophil  death  by  "-'50%  during  the  72-h 
time  course.  This  partial,  but  not  complete,  inhibition  of 
neutrophil  death  suggests  that  the  Fas/FasL  pathway  is  an 
important,  but  not  exclusive,  mechanism  involved  in  the 
regulation  of spontaneous  neutrophil  apoptosis.  We  inter- 
pret  these  results  to  indicate  that  redundant  mechanisms 
exist  to  insure  that  neutrophils  undergo  apoptosis  in  the 
event that the Fas pathway is interrupted  or fails. Thus,  we 
propose  that  the  Fas/FasL  pathway  may  represent  a  key 
mechanism  regulating  the  rapid  spontaneous  turnover  of 
neutrophils  after their release from the marrow. 
Our  results  demonstrate  differential  sensitivity  among 
neutrophils, monocytes, and eosinophils to Fas-induced apop- 
tosis  (Fig.  3).  Although  all three  types of phagocytes were 
shown  to  express  cell-surface  Fas,  only  neutrophils  were 
found  to  undergo  rapid  apoptosis  after  stimulation  with 
mAb CH-11.  In monocytes, mAb CH-11  induced  a mod- 
est,  albeit statistically significant,  degree  of DNA  fragmen- 
tation.  Thus,  the  observed  magnitude  of apoptosis  in  our 
study differs from a previous report, suggesting that mono- 
cytes  exhibit  relatively high  sensitivity  to  the  Fas  apoptotic 
pathway  (49).  Moreover,  the  relative  sensitivity  of  the 
phagocyte  populations  to  Fas-induced  apoptosis  correlated 
with  the relative rate  of spontaneous  apoptosis observed in 
vitro  (i.e.,  neutrophils  >monocytes  >eosinophils)  (6-16, 
46).  Both  proinflammatory  cytokines  and  dexamethasone, 
an antiinflammatory  glucocorticoid,  suppressed  Fas-induced 
apoptosis  in  normal  neutrophils  (Figs.  4-6),  in  a  manner 
similar to their effects on spontaneous  apoptosis and viahil- 
ivy  of neutrophils  maintained  in  vitro  (6,  9,  10).  Of the 
proinflammatory cytokines investigated in our study, G-CSF 
exerted  the  strongest  effect  on  reducing  spontaneous  (58) 
and Fas-induced  neutrophil apoptosis (Figs. 4 and 5). Lesser 
but  significant  reductions  in  Fas-induced  apoptosis  were 
observed with GM-CSF,  IFN-% and TNF-o~ (Fig.  4). To- 
gether,  these  findings  are  consistent  with  the  hypothesis 
that  proinflammatory  cytokines  and  glucocorticoids  sup- 
press neutrophil  apoptosis via inhibition  of a component  of 
the Fas death program. 
The  mechanism  by  which  proinflammatory  cytokines 
and  glucocorticoids  mediate  their  antiapoptotic  effects has 
yet to be  determined.  We  doubt  that simple  downregula- 
tion of cell-surface Fas expression is involved, based on our 
observation that incubation  with G-CSF in vitro fails to al- 
ter  the  MFI  signal  for Fas  in  flow  cytometry  experiments 
(data not  shown).  Ceramide,  generated by activation of an 
acidic sphingomyelinase,  has also been implicated as an ira- portant intracellular messenger of the Fas death pathway in 
several  cell  types,  including  lymphocytes  (51,  52).  Al- 
though  we  cannot  exclude  the  possibility that  ceramide  is 
an Fas-induced  intracellular messenger of apoptosis in neu- 
trophils,  we have failed to observe accelerated  apoptosis in 
neutrophils  treated with C 2 ceramide  (Liles, W.C.,  and S.J. 
Klebanoff,  unpublished  data),  a  cell  permeable,  synthetic 
analogue of endogenous  free ceramide  capable of inducing 
apoptosis in other cell types (51, 52).  Fas activation has also 
been  found  to stimulate  an  elevation  in  the  concentration 
of cytosolic Ca  2+ in certain cell types (53). Although  a po- 
tential role for a Fas-mediated Ca  2+ signal has yet to be de- 
scribed  in  phagocytes,  it  is  interesting  to  note  that  small, 
transient elevations in intracelluar Ca  2+ have been reported 
to paradoxically inhibit apoptosis in normal human neutro- 
phils (54). 
Induction  of antiapoptotic  oncogene  expression  repre- 
sents  another potential  mechanism  for inhibition  of apop- 
tosis.  Bd-2  and  related  oncogenes  such  as  bcl-x  have  re- 
ceived  substantial  attention  because  of  their  ability  to 
inhibit  apoptosis in a variety of systems (55-57),  including 
hematopoietic  development  (58,  59).  The  relative  resis- 
tance  of monocytes  to  Fas-induced  apoptosis  has been  at- 
tributed  to expression  of the  antiapoptotic  gene  bd-2  (16). 
Furthermore,  mice deficient in bcl-2 expression suffer mas- 
sive  death  of hematopoietic  precursors,  and  spontaneous 
apoptosis  is  significantly  impaired  in  mature  neutrophils 
from transgenic mice that express bcl-2 (4).  However, nei- 
ther bcl-2 nor bd-x is expressed in mature neutrophils, nor are 
they induced by treatment with G-CSF in vitro (Liles, W.C., 
J.R.  Park,  D.M.  Hockenbery,  and  S.J.  Klebanoff,  unpub- 
lished data). Our findings suggest that proinflammatory cy- 
tokines  and  glucocorticoids  may  modulate  Fas-mediated 
signal  transduction,  thereby  suppressing  both  Fas-induced 
and  spontaneous  apoptosis  of  normal  neutrophils.  The 
demonstration  that both  genistein  and  herbimycin  A  sup- 
press apoptosis in neutrophils stimulated with mAb CH-11 
is consistent  with this hypothesis  (Figs.  5  and 7),  especially 
in light of the recent report implicating an essential role for 
tyrosine  kinase  activity in  Fas-mediated  signalling  in  lym- 
phocytes  (39).  Furthermore,  we  have  recently  found  that 
spontaneous  neutrophil  apoptosis  in  vitro  is partially  sup- 
pressed by both genistein and herbimycin A  (50). 
The  neutrophil  is  recognized  as  an  important  cellular 
mediator of tissue damage during inflammation  (60).  It has 
been  hypothesized  that release  of sFasL from lymphocytes 
represents  a pathologic pathway to promote injury in  Fas- 
susceptible tissues (32, 43). The finding that neutrophils re- 
lease  a  soluble  factor  that  induces Jurkat  cell  death  via  a 
mechanism sensitive to either antagonistic  anti-Fas IgG 1 or 
Fas-Ig (Fig. 9) suggested that the neutrophil  also may serve 
as  a  source  of sFasL.  Nomlally,  senescent  neutrophils  are 
removed  from  an  inflammatory  site  by  macrophages  via 
phagocytosis  (1).  It is believed  that  this  process  minimizes 
the  potential  risk  of tissue  injury  related  to  the  release  of 
neutrophil-derived  toxic  mediators  (1).  Conceivably,  fail- 
ure of this system to recognize and remove senescent neu- 
trophils  could lead to increased  FasL release and  exacerba- 
tion of tissue injury at sites of inflammation. 
Immunoblot analysis confirmed that a soluble 30-kD pro- 
tein recognized  by an mAb specific for human  FasL is re- 
leased  into  the  culture  supernatant  of neutrophils  main- 
tained in vitro.  Thus, we propose that neutrophils  may not 
only facilitate their  own  suicide,  but  also induce  apoptosis 
in heterologous  cells via the  Fas death  program.  The solu- 
ble  30-kD  protein  detected  in  our  FasL  immunoblot  ex- 
periments  is  slightly  larger  than  the  26-kD  sFasL  released 
from activated T  cells (32). Recently,  a matrix metallopro- 
teinase was implicated in the mechanism responsible for the 
release  of sFasL from lymphocytes  (43).  The  difference  m 
molecular mass of the  neutrophil-derived  product  suggests 
that  the  proteolytic  mechanisms  regulating  the  release  of 
sFasL from neutrophils  and lymphocytes may differ.  Thus, 
it will be of considerable interest to examine whether a spe- 
cific  neutrophil-derived  metalloproteinase  mediates  shed- 
ding of biologically active sFasL from normal human  neu- 
trophils. 
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